Endotoxin activity dosage in septic patients


Submitted: 14 February 2014
Accepted: 14 February 2014
Published: 30 June 2010
Abstract Views: 834
PDF: 938
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Endotoxin (LPS), present in the outer membrane of Gram negative bacteria, is responsible for a series of biological effects, primarily linked to the lipid fraction (Lipid A).The aim of our work was to correlate the endotoxin activity with the risk of severe sepsis in patients showing severe bacterial infection and hospitalized in the three Intensive Care Units of the AUSL BAT. Fifty-three endotoxin activity (EA) blood tests were performed on 28 septic patients. 17/28 (60.7%) patients showed EA > 0.60 (associated with high risk of severe sepsis). Endotoxin activity (EA) blood tests were repeated in 11/17 cases after LPS removal by extracorporeal blood treatment with Polymyxin B (Toraymyxin). 6/11 patients had a reduction of LPS in the bloodstream after 1 treatment with Toraymyxin; in 5 of these 6 patients there was a further reduction after 2 treatments with Toraymyxin. EA dosage has been proven either a method for the diagnosis of severe sepsis due to Gram negative bacteria or helpful means in selecting patients for treatment with Toraymyxin.

Del Gaudio, T., Distasi, M. A., Porzio, M., Mosca, A., & Miragliotta, G. (2010). Endotoxin activity dosage in septic patients. Microbiologia Medica, 25(2). https://doi.org/10.4081/mm.2010.2466

Downloads

Download data is not yet available.

Citations